Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07779356) titled 'Patient Comfort Following Intravitreal Injections Using Iheezo Versus Standard Anesthesia' on Aug. 19.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Retina Consultants of Delmarva
Condition:
Macular Degeneration
Diabetic Retinopathy
Retinal Vein Occlusion (RVO)
Intervention:
Drug: Iheezo
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: May 20, 2026
Target Sample Size: 50
Countries of Recruitment:
United States
To know more, visit https://cl...